Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battle
Johnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby powder and other talc products caused ovarian cancer, in a landmark deal that could end a contentious, decade-long legal battle.
Johnson & Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, representing nearly all of the remaining talc claims against the company.